Jim Cramer, the host of Mad Money, helped viewers on Friday make sense of the kind of chaotic trading that can rattle even seasoned investors.
“How did I know to tell you to be ready to buy when the time was right, like I did last night after yesterday’s brutal session?… It’s all about how to spot a bottom. It all starts with something called the S&P Oscillator. It’s a proprietary measure of buying and selling pressure put out each night after the close of the market by a company called MarketEdge.”
READ ALSO 11 Stocks Jim Cramer Recently Offered Insights On and Jim Cramer Answered Questions About These 7 Stocks
Cramer walked through how he uses it: when the oscillator sits at zero, nothing meaningful can be read from it. He said that a reading of +5 signals that investors have become too excited and that it is time to trim positions. At +10, he said the situation is so overheated that an investor should unload almost everything except a small set of core holdings, though he emphasized that such extremes are unusual. The same idea applies when the market is falling. He explained that a reading of -5 means conditions have become oversold and that it is time to start buying because a rebound is likely.
“Now I know this sounds like hocus pocus, but this is what I did for a living in my hedge fund for years and years and years. I picked bottoms and tops. I even wrote about it in a book called Real Money. So I had the tells, I had the cards, I heard the thunder of the herd, and I nailed it. Maybe it sounds crazy when I say stocks talk to me, but they do. Maybe after all these years, they just like me. I think it’s good to have friends in high places.”
Our Methodology
For this article, we compiled a list of 14 stocks that were discussed by Jim Cramer during the episode of Mad Money aired on November 21. We listed the stocks in the order that Cramer mentioned them. We also provided hedge fund sentiment for each stock as of the second quarter of 2025, which was taken from Insider Monkey’s database of over 900 hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).
14 Stocks Jim Cramer Recently Shed Light On
14. Sandisk Corporation (NASDAQ:SNDK)
Number of Hedge Fund Holders: 49
Sandisk Corporation (NASDAQ:SNDK) is one of the stocks Jim Cramer recently shed light on. During the episode, Cramer highlighted Sandisk as one of the stocks that set the tone for the market before NVIDIA moved. He stated:
“Yesterday, everyone thought the only tell was, matter was NVIDIA, right? Well, when it turned down, they thought it was the end. That was wrong. What actually led us down yesterday were the stocks of Micron and Sandisk, two plain vanilla tech storage plays that had been red hot but suddenly turned ice cold. They plummeted, and then and only then did NVIDIA give up the ghost. So I knew to watch the action in those two as a prelude to any rally…
I knew that once Micron and Sandisk, the two that had led us down yesterday, went lower and then reversed, well, then I knew we’d be home free. That’s what led us down yesterday, not NVIDIA. The crescendo was happening right in front of me. Then, when NVIDIA started printing higher highs and higher lows after a horrendous opening, it was a run for the roses.”
Sandisk Corporation (NASDAQ:SNDK) sells NAND flash-based storage solutions, including solid-state drives, embedded storage, removable cards, and USB drives.
13. Biohaven Ltd. (NYSE:BHVN)
Number of Hedge Fund Holders: 39
Biohaven Ltd. (NYSE:BHVN) is one of the stocks Jim Cramer recently shed light on. During the lightning round, when a caller inquired about the stock, Cramer stated:
“Okay, well, I’ll tell you in full disclosure, I have a deal with Biohaven over a drug that I’ve invented with a doctor. So I will tell you the stock seems very low to me. But then again, because I do have that deal, you might just say, well, wait a second, Cramer’s, you know, how can you tell? But boy, is it low.”
Biohaven Ltd. (NYSE:BHVN) develops treatments for neurological, psychiatric, autoimmune, and cancer-related conditions, with several drugs in clinical trials. A caller asked about the stock during the May 29 episode, and Cramer responded:
“Alright, Biohaven had an analyst day the other day, and it was, you know, people didn’t get excited about it. Now, in full disclosure, I do have a personal deal with Biohaven, and I don’t talk about it much because it’s not been disclosed, but I am surprised this stock is all the way down here. Vlad Coric is really good. I think that this is a buy, but you could say, hey Cramer, you’re biased, you got a deal with them. But I’m just telling you that’s how I feel, or else I wouldn’t have a deal with them.”
